Vertex Pharmaceuticals partners with XO Life to offer digital therapy support for cystic fibrosis patients via the briteTM platform

Vertex Pharmaceuticals, a global biotech leader in the field of hard-to-treat diseases such as cystic fibrosis (CF), has announced a strategic partnership with digital health scale-up XO Life. The goal is to provide digital therapy support for people living with cystic fibrosis via the briteTM platform.

At the center of the initiative is a new section on the briteTM platform – available via web or app – specifically targeting patients receiving treatment for cystic fibrosis (CF).

Through the briteTM platform, XO Life offers a one-stop shop for digital patient support, combining pharmaceutical and medical content, personalized guidance, expert support, and peer exchange.

This partnership with Vertex marks a milestone, as a leading pharmaceutical company chooses a scalable, data-driven, and user-friendly solution rather than building isolated custom apps.

Patients will gain access to validated content, tailored treatment-related questions, medical support, and a secure community – enhancing adherence, trust, and better treatment outcomes.